I suggest you to run our pipeline for detection of neoantigens, and also calculation of CSiN, which may be more accurate
Modifying your neoantigen/mutation data for input into CSiN.R is a little difficult. If you insist on doing this, I suggest you to run our mutation calling and neoantigen calling pipelines on some example data, and check the output format of everything before the point of CSiN.R. Then mimic that format for your data.
Thanks!
Tao
Copyright: Content may be subjected to copyright.
How to cite:
Readers should cite both the Bio-protocol preprint and the original research article where this protocol was used:
Wang, T(2022). The CSiN score and the other neoantigen-based metrics used for comparison. Bio-protocol Preprint. bio-protocol.org/prep1610.
Lu, T., Wang, S., Xu, L., Zhou, Q., Singla, N., Gao, J., Manna, S., Pop, L., Xie, Z., Chen, M., Luke, J. J., Brugarolas, J., Hannan, R. and Wang, T.(2020). Tumor neoantigenicity assessment with CSiN score incorporates clonality and immunogenicity to predict immunotherapy outcomes . Science Immunology 5(44). DOI: 10.1126/sciimmunol.aaz3199
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.
0/150
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.
Spinning
Post a Question
0 Q&A
Spinning
This protocol preprint was submitted via the "Request
a Protocol" track.